0001179110-20-003226.txt : 20200306 0001179110-20-003226.hdr.sgml : 20200306 20200306161010 ACCESSION NUMBER: 0001179110-20-003226 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200305 FILED AS OF DATE: 20200306 DATE AS OF CHANGE: 20200306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Levy Lewis CENTRAL INDEX KEY: 0001726568 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 20694865 MAIL ADDRESS: STREET 1: C/O TELADOC, INC. STREET 2: 2 MANHATTANVILLE ROAD, SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 edgar.xml FORM 4 - X0306 4 2020-03-05 0 0001477449 Teladoc Health, Inc. TDOC 0001726568 Levy Lewis C/O TELADOC HEALTH, INC. 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 0 1 0 0 Chief Medical Officer Common Stock 2020-03-05 4 M 0 3207 A 9569 D Common Stock 2020-03-05 4 F 0 1398 132.73 D 8171 D Common Stock 2020-03-05 4 M 0 2467 A 10638 D Common Stock 2020-03-05 4 F 0 711 132.73 D 9927 D Common Stock 2020-03-05 4 S 0 1982 126.51 D 7945 D Performance Stock Units 2020-03-05 4 M 0 3207 0.00 D Common Stock 3207 6416 D Restricted Stock Units 2020-03-05 4 M 0 2467 0.00 D Common Stock 2467 4935 D Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. On February 26, 2020, the reporting person earned 9,623 performance stock units, vesting in three annual installments beginning on March 4, 2020. On March 4, 2019, the reporting person was granted 7,402 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019. /s/ Adam C. Vandervoort, attorney-in-fact 2020-03-06